hotspot -WSS

hotspot

author：comprehensive 2025-09-14 21:56:18 - browse：49

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration said Monday that it has deep reservations about NurOwn, an investigational ALS treatment from BrainStorm Cell Therapeutics, citing a lack of evidence that the medicine works and the company’s failure to demonstrate that it can properly manufacture the product.

In documents disclosed ahead of a Wednesday public hearing on NurOwn’s application for approval, the FDA detailed its problems with a clinical trial that missed its primary objective and noted that BrainStorm submitted “grossly deficient” information on how the medicine is made, voicing “major concerns that the available data do not meet the statutory standard of substantial evidence of effectiveness to support” approval.

BrainStorm filed for approval over the FDA’s protest, insisting that NurOwn has demonstrated benefits for a subset of ALS patients with milder disease. That conclusion, based on an after-the-fact analysis of the company’s failed pivotal trial, has proved polarizing among patients and physicians, with some arguing that the FDA should exercise flexibility in light of the irrevocably fatal nature of ALS and others demanding BrainStorm conduct another clinical trial to demonstrate its benefits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Scientists find bacteria from stomach of ancient iceman

WSS

People with mental disorders often marry others with same

Bird flu reported in person exposed to presumably infected cattle

Florida Supreme Court upholds state's abortion ban

Russian court extends detention of American musician

Study: Black kids more likely to die after surgery than white kids

California Joshua trees severely burned in massive wildfire

Wikipedia

hotspot

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Study: Black kids more likely to die after surgery than white kids

ChatGPT in medicine: STAT answers readers' burning questions

Lifetime voting ban for felony convictions struck down in Mississippi

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medical mystery: When an infection after surgery isn’t what it seems

After affirmative action ruling, medical educators look to 'holistic review'

Hundreds died while taking an arthritis drug, but nobody alerted patients

Anesthesiologist group: stop taking Ozempic before surgery

Medical mystery: When an infection after surgery isn’t what it seems

hotspot

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Special counsel alerts court to Trump’s social media post

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

leisure time

hotspot

hotspot

leisure time